跳至主要内容
临床试验/NCT01107379
NCT01107379已完成不适用

Optimization and Refinement of Technique in In-Office Sinus Dilation 2 (ORIOS 2)

Integra LifeSciences Corporation0 个研究点目标入组 203 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
203
主要终点
Mean Intra-patient Change in SNOT-20 Score

研究概览

简要总结

A prospective, multi-arm, multi-center, observational post-market study of balloon sinus dilatation in the physician office setting under local anesthesia to treat patients with chronic rhinosinusitis (CRS). All products intended for use in this study have been FDA cleared for sale in the U.S.A.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male/Female, 18 year or older
  • •Diagnosis of Chronic Rhinosinusitis
  • •Planned Endoscopic Sinus surgery

排除标准

  • •Cystic Fibrosis
  • •Severe Polyposis
  • •Sinonasal tumors
  • •History of facial trauma precluding access to sinus ostium
  • •Ciliary Disfunction
  • •Planned non-sinus surgery (such as rhinoplasty, septoplasty, etc.)
  • •Pregnant or lactating female
  • •Inability to tolerate an awake procedure
  • •Participation in another investigational clinical study involving treatment for chronic rhinosinusitis

结局指标

主要结局

Mean Intra-patient Change in SNOT-20 Score

时间窗: Baseline and 24 weeks

Change in patient-reported quality of life survey, Sino-Nasal Outcome Test -20 (SNOT-20), using paired baseline and 24 week data. The 20 question Sino-Nasal Outcome Test (SNOT-20) will be used to evaluate sinus symptoms and sinus-symptom related quality of life (QOL) at baseline and 24 weeks post-procedure. The change in SNOT-20 score at 24 months will be compared to the baseline SNOT-20 score. Each of the 20 questions in the SNOT-20 survey is scored on a scale of 0 to 5, where '0' represents 'no problem' and '5' represents 'problem as bad as it can be'. The 20 questions are expressed as a mean of the scores. Therefore, the minimum mean score is zero and the maximum mean score is 5.

Mean Intra-patient Change in Lund-Mackay CT Scan Score

时间窗: Baseline and 24 weeks

Change in Lund-Mackay CT score for paired baseline and 24 week data. The Lund-MacKay (LMK) CT (computed tomography) score is a scoring system to evaluate radiographic opacification of the paranasal sinuses. The LMK score will be evaluated at 24 weeks post-procedure compared to baseline. The LMK scoring system rates each of both the left and right frontal, maxillary, sphenoid, ostiomeatal complex, anterior ethmoid and posterior ethmoid sinuses on a scale of 0 to 2, where '0' is 'no opacification' and '2' is 'complete opacification'. The scores for a given subject are totaled and expressed as the LMK score, where zero is the minimum score, and 24 is the maximum score. A higher score represents greater sinus disease burden.

次要结局

  • Procedure Tolerability(Day 0 (Day of Procedure))
  • Proportion of Sinuses Successfully Treated in the Office Using Balloon Catheter Tools and Traditional Endoscopic Tools as Necessary(Day 0 (Day of Procedure))
  • Proportion of Sinuses Successfully Treated in the Absence of Serious, Procedural Adverse Events.(Day 0 (Day of Procedure))
  • Mean Number of Days to Return to Normal Activities(2 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验